We also identified variations in several genes, including MAP3K1 (14) and ERCC5 (15), known to influence chemotherapy sensitivity, and ATM, ATR (16)and RBM10 (17), which are involved in DNA repair and tumor immunity. Here, MAP3K1 is linked to neoplasm.